Pressemitteilungen zu dem Thema medicine


Unterkategorien

PresseMitteilungen zu dem Schlagwort medicine


NJ Holistic Doctor Michael Rothman Discusses Telemedicine and the Limits of Technology

Wall, NJ The article contains observations about how telemedicine is contributing to an increasing distance between the patient and the physician. More is available at: http://mdwellnessmd.com/blog/post/telemedicine-when-is-technology-too-much/ While Dr. Dr. Rothman doesn''t necessary think that telemedicine is a full encompassing solution for the patient-doctor relationship, he does appreciate it for certain situations. Phone consultations and alike situations are acceptable. He ...


13.03.2018

New Publication on Dinshah P. Ghadiali & his Spectro-Chrome therapy

Contemporary science is validating light and color as a beneficial therapeutic tool. It has been generally accepted that light and color affect the mind and body. Violent juveniles placed in a pink detention cell will relax, stop banging and yelling, and fall asleep within ten minutes. An estimated 1,500 hospitals and correctional institutions have incorporated the pink color in at least one room in their facilities. Conventional medicine uses color-light therapy in several ways. Blue light the ...


06.02.2018

Redsenol Series: The era of multi-component rare ginsenoside products

Ginsenosides are natural compounds extracted from Araliaceae plants like Panax ginseng. Since ginsenosides were found to exhibit anticancer property in the 1960s, scientists have been working on the study of rare ginsenosides. With the in-depth research on ginsenosides, scientist found that rare ginsenosides, the metabolite of prototype ginsenosides, exhibit more potent anticancer activities in many aspects, including inhibiting angiogenesis in malignant lesions, alleviating toxicity induced by ...


03.02.2018

Canada Royal Enoch: an ambitious runner in phytomedicine research and application

Canada Royal Enoch Phytomedicine Ltd, located in Vancouver, Canada, is a hi-tech company mainly engaged in research, production and sales of natural plant-based medicines. The company is led by led by Chinese-Canadian scientist Joshua Yu who devoted himself into the phytomedicine research and application for years. The company aims to extract active anticancer ingredients from natural medicinal plants to assist the treatment and recovery of cancer. Focusing on the research of rare ginsenosides ...


03.02.2018

Over 20 years of radioimmunoassays for diabetes diagnostics!

20 years of radioimmunoassays for diabetes diagnostics - Why should radioactive test reagents still be used in diagnostics, as nowadays more and more people disapprove radioactive technology? To put it simple: many areas of modern medicine would not be possible without the use of radioactive treatments, and in the field of diagnostics there are many radioactive test reagents that are still recognized as gold standard methods. Today the number of companies still offering radioimmunoassay (RIA) r ...


19.01.2018

Global Precision Medicine Market 2023 : Focus on Industry, Growth, Size, Share, Dynamic Research Analysis, Trend, Forecast - Credence Research

The latest market report published by Credence Research, Inc. Browse the full Market Insights Precision medicine is a new technology applied for treatment and prevention of chronic diseases based on the variability in individual genes and other lifestyle characteristics. In precision medicine, diagnostic testing is frequently employed for selecting suitable and optimal therapies based on the framework of a patient part of patient care, enabling physicians to select treatments that improve cha ...


17.01.2018

Scope Creates Drug Monographs for a Leading Health Portal

Scope e-Knowledge Center (Scope), a leading provider of specialized knowledge services for publishers and information providers, is pleased to announce the successful delivery of 135 drug monographs for one of the world Drug monographs were developed for drugs approved by the European Medicine Agency (EMA), as well as drugs not approved by the EMA but approved in selected countries outside the United States. The monographs allow users to easily evaluate the safety, tolerability and efficacy of ...


11.01.2018

Complete Care Medicine Asks for Toy Donations

The holiday season is in full swing at Complete Care Medicine in Gilbert, Arizona. The doctors and staff at the Gilbert health center are asking everyone to take a few minutes during their preparations for this yearrough Dec. 22. Arrangements will be made to have all donated toys delivered to needy children in time for the holidays. Offering a full range of health care for all patients from newborns to the elderly, Complete Care Medicine has established itself as the Gilbert family physician p ...


15.12.2017

Pharmaceutical Companies Poised to Build Infrastructure to Accommodate Real World Evidence, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 11/08/17 -- Real world evidence is poised to play a growing role in drug development during the next three years, but the availability and cost of acquiring data remain key challenges, according to a recently completed study conducted by the .Large pharmaceutical, biotechnology, and contract research organizations plan to increase internal staff dedicated to collection and analysis of real world data by 25% between now and 2020, according to a survey conducted by ...


08.11.2017

Probiotics, Omega-3 and Oscillococcinum on Doctor''s Short List for Cold and Flu Season

NEWTOWN SQUARE, PA -- (Marketwired) -- 11/01/17 -- Health experts are bracing for what could be a rough cold and flu season. Knowing the difference between a cold and flu can give you a slight advantage. Being prepared with a two-week supply of supplements including probiotics and omega-3, in addition to the homeopathic medicine, Oscillococcinum by Boiron, can help shorten the duration and severity of the illnesses.The World Health Organization estimates that 3- to 5-million people worldwide co ...


01.11.2017

Manage Stress & Relieve Pain With Reno Nevada Acupuncture From This Alternative Medicine Specialist

A Reno, Nevada alternative medicine specialist has launched a new report on the benefits of acupuncture for stress management. Reno Alternative Medicine explains that stress aggravates chronic pain, and modern life can create higher levels of stress than ever. This can have some negative effects when it comes to managing chronic pain. More information can be found at: https://RenoAlternativeMedicine.com. When people are dealing with high levels of stress, it can lead to chronic pain such as ar ...


30.10.2017

National Certification Commission for Acupuncture and Oriental Medicine(R) Applauds the National Association of Attorneys General Initiative in Fight Against Opioid Crisis

JACKSONVILLE, FL -- (Marketwired) -- 10/30/17 -- The (NCCAOM)®, which has long stressed the importance of non-drug approaches to chronic pain, commends the National Association of Attorneys General (NAAG) for its September 18th encouraging healthcare providers to prioritize non-opioid pain management options over opioid prescriptions for the treatment of chronic pain. The letter addresses the necessity for doctors to explore, prescribe and refer patients for effective non-drug treatments such ...


30.10.2017

The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual 2017 European Advanced Therapies Investor Day

LONDON, UNITED KINGDOM and WASHINGTON, DC -- (Marketwired) -- 10/17/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, along with co-hosts UK BioIndustry Association (BIA) and the Cell and Gene Therapy Catapult, releases the agenda for its annual European Advanced Therapies Investor Day, to be held November 9, 2017 in London.Now in its fifth year, this one-day, invitation-on ...


17.10.2017

The Alliance for Regenerative Medicine Announces Election of 2018 ARM Executive Committee and Board of Directors

WASHINGTON, DC -- (Marketwired) -- 10/04/17 -- The Alliance for Regenerative Medicine (ARM), announced today the election of its 2018 Executive Committee and Board of Directors.The Executive Committee and Board of Directors oversee the formation and execution of ARM''s strategic priorities and focus areas over the coming year. Each group is held to an annual re-election or rotation process, with nominations and approval by the ARM membership and current Board."We are excited to w ...


04.10.2017

Nokia, Verizon and Vertix Consulting Join Jaymie Scotto & Associates (JSA) Virtual CEO Roundtable on Telemedicine September 29

MIDDLEBROOK, VA -- (Marketwired) -- 09/26/17 -- , the preeminent provider of Public Relations, Marketing and Event Planning services to the tech and telecom industries, today announces its latest Virtual CEO Roundtable installment, "," to be webcast on Friday, September 29 at 11:30 AM ET.JSA''s Dean Perrine, Vice President of New Media and Account Strategy, will moderate and lead the important discussion between panelists: John Gardner, Partner of ; Nancy Green, Global Pract ...


26.09.2017

The Alliance for Regenerative Medicine Submits Letter to Congress Detailing Concerns with the Senate''s American Health Care Act

WASHINGTON, DC -- (Marketwired) -- 09/22/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, today sent a letter to U.S. Sens. Graham (R-SC), Cassidy, MD (R-LA), Heller (R-NV) and Johnson (R-WI), detailing concerns regarding the American Health Care Act (H.R. 1628).The letter, signed by ARM CEO Janet Lambert, addresses the organization''s primary concern that ...


22.09.2017

Bundled competences for an optimum product solution – OKW, ANSMANN AG and Hoffmann + Krippner

In principle, the basic structure of every electronic device is always the same. First you need the relevant electronics that are to be installed. Then they need protection by means of a suitable enclosure, an operating unit such as a touch panel or keyboard, and of course a suitable power supply using batteries etc. The field of application does not matter, whether it is building technology, medical and laboratory technology or machine and plant engineering. OKW Gehäusesysteme offers a wide ran ...


21.09.2017

First GREEN Bank and The Collage Companies Present Second Annual Art of Medicine Gala This October 20

ORLANDO, FL -- (Marketwired) -- 09/20/17 -- The Art of Medicine Foundation announces today its second annual presented by First GREEN Bank and The Collage Companies. The gala takes place on October 20 and will benefit the University of Florida''s Trauma, Concussion, and Sports Neuromedicine Program (UF TRACS), which is dedicated to traumatic brain injury diagnosis, treatment and research. The gala is designed to educate and inspire each guest, raise awareness for physician and brain ...


20.09.2017

Cardiovascular Drug Approval Rate in the U.S. Fell as Development Time Rose, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 09/12/17 -- Although the rate at which investigational drugs received marketing approval in the United States has declined in recent years, the cardiovascular approval rate trailed other drug approvals as a whole, while the time needed to develop cardiovascular drugs rose, according to a recently completed study conducted by the .Approval success rates for cardiovascular compounds fell from about 5.2% for compounds that began clinical testing during 1995-00, to ab ...


12.09.2017

Asana Medical, Inc. to Present as Innovation Challenge Finalist at RESI Boston Conference 2017

MIAMI LAKES, FL -- (Marketwired) -- 09/11/17 -- ., ("Asana," the "Company"), a regenerative medicine company developing a novel treatment for Ulcerative Colitis, is pleased to announce that it has been selected as an Innovation Challenge Finalist and will present at the in Boston, Massachusetts on Tuesday, September 26th, 2017. The RESI (Redefining Early Stage Investments) Conference is an investor conference for early-stage life science companies, and is being held at the ...


11.09.2017

Dr. Susan G. Manella Joins Asana''s Medical Advisory Board

MIAMI LAKES, FL -- (Marketwired) -- 08/24/17 -- ., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn''s Disease, is pleased to announce that Dr. Susan G. Manella has accepted the Company''s offer to join its Medical Advisory Board. Dr. Manella will assume the board''s leadership role in managing information flow a ...


24.08.2017

The Alliance for Regenerative Medicine Releases Q2 2017 Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 08/18/17 -- The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the second quarter and first half of 2017.Using information provided by ARM''s data partner Informa, the quarterly data report details industry-specific statistics compiled from more than 822 cell ...


18.08.2017

Internalmedicineresidency.biz extends its toll-free phone support to customers in Europe and Asia

London, UK, July 30th 2017 - internalmedicineresidency.biz has announced that it will be extending its toll free phone support to customers who are based in Europe and Asia. This is part of the company’s big plan to expand its services and reach as many customers as possible around the world looking for professional help with writing internal medicine residency personal statement. Customers who have queries and other issues can reach the bank anytime since the company has opened a channel that c ...


29.07.2017

The Alliance for Regenerative Medicine Issues Statement in Response to Reports of the First Use of Gene Editing Technology in Human Embryos in the U.S.

WASHINGTON, DC -- (Marketwired) -- 07/27/17 -- The Alliance for Regenerative Medicine (ARM) has issued the following statement in response to the news that a research team from the Oregon Health and Science University has, for the first time in the United States, utilized gene editing technology to modify human embryos:ARM continues to monitor the latest developments in gene-editing technologies, given their enormous medical potential. We reiterate our encouragement and support of the use of th ...


27.07.2017

Residencyapplicationpersonalstatement.com reiterates its commitment to offer high quality services to its clients

London, UK, June 27th 2017- residencyapplicationpersonalstatement.com has moved in to assure its clients that they will continue to offer high quality services to its clients. This assurance has come at a time when the company has been facing a stiff competition from other companies providing residency application personal statement writing services. The company fully understands the need to offer its customers with reliable services. According to a statement from the company, the move is aimed ...


27.07.2017

The Alliance for Regenerative Medicine Announces Second Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo

WASHINGTON, DC -- (Marketwired) -- 07/24/17 -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, "New Payment and Financing Models for Curative Regenerative Medicines," available today in In Vivo.Authored by Ted Slocomb of Audentes Therapeutics; Ted Haack of LatticePoint Consulting; Satish Valluri of Pfizer; Beth Rader of BioMarin; and Michael Werner of ARM, this white paper, the second in ARM' ...


24.07.2017

The Alliance for Regenerative Medicine Announces Presenting Companies at 2017 Cell & Gene Meeting on the Mesa

WASHINGTON, DC -- (Marketwired) -- 07/19/17 -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of companies selected to present at its upcoming Cell & Gene Meeting on the Mesa annual conference, October 4-6, 2017.Over the course of the three-day conference, more than 850 are expected to attend, including executives from leading companies, venture capital and institutional investors, tools and development platform providers, clinicians, patients and patient adv ...


19.07.2017

The Joint Commission Introduces Revised Pain Assessment and Management Standards, for Accredited Hospitals, to Include Use of Non-Pharmacologic Treatments and Strategies

JACKSONVILLE, FL -- (Marketwired) -- 07/13/17 -- The (NCCAOM)®, which has long advocated non-pharmacological treatments, commends The Joint Commission, an independent, not-for-profit organization that accredits nearly 21,000 health care organizations and programs in the United States, for their . The updated standards, effective January 1, 2018, will require Joint Commission accredited hospitals to provide nonpharmacological pain modalities, including acupuncture as one option, by licensed ind ...


13.07.2017

Abuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 07/13/17 -- Although 10 new opioid products with abuse-deterrent formulations (ADF) have received regulatory approval in the United States, lack of willingness by insurers to reimburse patients for their use is seen as a primary challenge limiting ADF uptake, according to the .According to Tufts CSDD, 96% of all opioid products prescribed in the U.S. in 2015 lacked abuse-deterrent properties, and only four of the 10 opioid products with abuse-deterrent properties ...


13.07.2017

PolarityTE(TM) Expands Clinical Board of Advisors with Focus on World-Renowned Burn and Wound Care Specialists

SALT LAKE CITY, UT -- (Marketwired) -- 06/30/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of some of the world''s most-highly-regarded experts in burn and wound care to its Clinical Board of Advisors, as it drives toward the introduction of the Company''s flagship product, SkinTE™. This cadre of plastic and reconstructive surgeons includes Drs. Martin C. Robson, William L. Hickerson, Jeffrey W. Shupp, Mark S. Granick, David J. Smith, Jr. and Gerhard ...


30.06.2017

The Alliance for Regenerative Medicine Announces the Appointment of Janet Lynch Lambert as Chief Executive Officer

WASHINGTON, DC -- (Marketwired) -- 06/27/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, formally announces that its Board of Directors has named Janet Lynch Lambert as the organization''s first chief executive officer. The organization informed its membership early last week of the decision."We are delighted to add Janet to the ARM team at this very ...


27.06.2017

PolarityTE(TM) Appoints Distinguished Major General Jay Hood of the U.S. Army as Director of Newly Created Military and Mass Casualty Advisory Board

SALT LAKE CITY, UT -- (Marketwired) -- 06/27/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of Major General (U.S. Army - Retired) Jay Hood as the Director of the Company''s newly formed Military and Mass Casualty Advisory Board. Major General Hood amassed more than 36 years of service to the United States as an Army Officer."I am proud to announce the formation of the PolarityTE™ Military and Mass Casualty Advisory Board with the appointment of Major Gene ...


27.06.2017

PolarityTE(TM) Appoints Clinical Expert and Industry Insider Dr. Wayne Saunders to the Clinical Board of Advisors

SALT LAKE CITY, UT -- (Marketwired) -- 06/21/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced the appointment of Wayne J. Saunders, DMD to the Company''s Clinical Board of Advisors. Dr. Saunders is Chief of Oral and Maxillofacial Surgery and Dentistry at St. Luke''s University Hospital in Bethlehem, PA, and is widely-regarded as an expert in dental implants and maxillofacial trauma."As we develop the PolarityTE™ technology platform, we continue to leverage the exp ...


21.06.2017

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference

GLEN ROCK, NJ -- (Marketwired) -- 06/14/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders for which there are no approved pharmaceuticals, particularly sleep apneas and respiratory depression resulting from pain management medicines and disabilities such as spinal cord injury, announces that the Company''s President, Chief Executive Officer and Vice ...


14.06.2017

The Vancouver Cannabis Life Conference separates fact from stigma on July 7 & 8 at the Westin Bayshore

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/13/17 -- The Cannabis Life Conference Vancouver will gather vendors, industry experts, doctors, activists and consumers at the on July 7-8. This exciting two-day event will provide an informative journey for those passionate about cannabis, or curious, as they explore the opportunities of an alternative medicine. Attendees will experience a guided, behind the scenes tour into the emerging medicinal industry through a variety of intriguing pane ...


13.06.2017

BioStem Technologies, Inc. Announces Letter of Intent with Watermakers, Inc. to begin testing on Staniel Cay in the Exuma Cays, Bahamas

POMPANO BEACH, FL -- (Marketwired) -- 06/09/17 -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BSEM" or "the company"), a global corporation providing world-class solutions focused on Regenerative Medicines, Pharmaceuticals and Blue Technologies, is eager to announce that its Oakland Park, Florida based subsidiary, BioBlue Technologies Inc. ("BioBlue"), has signed a Letter of Intent ("LOI") with Watermakers, Inc. for industrial water treatment.Staniel Ca ...


09.06.2017

PolarityTE(TM) Regenerates Full-Thickness Hair-Bearing Skin in Burns and Wounds Using Their Revolutionary Platform Technology

SALT LAKE CITY, UT -- (Marketwired) -- 06/08/17 -- PolarityTE™, Inc. (NASDAQ: COOL) today announced pre-clinical results demonstrating that the Company''s lead product, SkinTE™, regenerated full-thickness, organized skin and hair follicles in third degree burn wounds. The findings represent the first known successful regeneration of skin and hair in full-thickness swine wound models, the standard animal model for human skin. The Company expects to initiate a human clinical trial evalu ...


08.06.2017

i2b2 Foundation and tranSMART Foundation Merge to Become the i2b2 tranSMART Foundation

WAKEFIELD, MA -- (Marketwired) -- 05/25/17 -- () - The tranSMART and i2b2 foundations today announce the completion of their merger to become the . The new organization is a global non-profit open-source foundation facilitating the further development of precision medicine and bringing it to practice.The mission of the i2b2 tranSMART Foundation is to enable effective collaboration for precision medicine through the sharing, integration, standardization, and analysis of heterogeneous data from h ...


25.05.2017

Paroxysmal Nocturnal Hemoglobinuria Overview and Pipeline Assessment - H1, 2017

Albany, New York, May 18, 2017: A new market report labeled as “Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H1 2017” has been added to the vast portfolio of Market Research Hub’s (MRH) online research offerings. This research report is a professional and in-depth analysis on the current state and future prospect of the Paroxysmal Nocturnal Hemoglobinuria market. It provides reliable information to industry insiders, potential entrants and investors. It includes a detailed analysis wit ...


18.05.2017

Global Hereditary Angioedema Market Estimated to Grow Steadily during the Period 2017-2021

Albany, New York, May 18, 2017: A new study focusing on a rare genetic condition, which is known as ‘Hereditary Angioedema’ has been added to the massive repository of Market Research Hub (MRH), and titled as “Global Hereditary Angioedema Market: Size, Trends & Forecasts (2017-2021)”. The report identifies the key trends shaping and driving the global Hereditary Angioedema market. The report also provides insights into the competitive scenario and the key players are expected to significantl ...


18.05.2017

Tetanus Pipeline Assessment and Therapeutic Activities Reviewed for H1 2017

Albany, New York, May 19, 2017: Tetanus is a frightening disease that has plagued mankind since ancient times. Market Research Hub (MRH) has recently broadcasted a pipeline study done on this bacterial disease and titled as “Tetanus - Pipeline Review, H1 2017”. This study examines comprehensive information on the therapeutics under development for Tetanus (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) an ...


19.05.2017

Global Personalized Medicine Partnering Trends and Major deals Analyzed during the Period 2010-2017

Albany, New York, May 19, 2017: The need to increase the number of new diagnostics and therapies for patients and to reduce the time and cost of developing them have directly resulted in more personalized medicine partnering, globally. To give more insight into the medicine partnering, Market Research Hub (MRH) has recently added an analyzed report titled as “Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts” to its vast report repository. The repo ...


19.05.2017

The Alliance for Regenerative Medicine Announces Speakers and "Legislator of the Year" Award Recipients for Eighth Annual Dinner and Legislative Fly-In

WASHINGTON, DC -- (Marketwired) -- 05/11/17 -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced the speaker line up for its eighth Annual Dinner and Legislative Fly-In, to be held May 23 and 24 in Washington, D.C. This event honors recent accomplishments in the sector and enables ARM members to advocate on Capitol Hill for legislative support of gene and cellular ...


11.05.2017

Aevi Genomic Medicine Announces Plans to Initiate Phase 2 Clinical Trial to Confirm Genetic Responders to AEVI-001 and First Quarter 2017 Operating Results

PHILADELPHIA, PA -- (Marketwired) -- 05/10/17 -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX)Company to initiate a Phase 2 clinical trial in 2H 2017, targeting a specific genetic subset of patients identified by a responder analysis of the SAGA trialResponder subset is approximately 10% of the US pediatric ADHD population and a total addressable market of $2 to $3 billionGenetic subset had a 90% response rate and stimulant-like effect in the SAGA trialPatients with the most commonly mutated gene, ...


10.05.2017

The Alliance for Regenerative Medicine Releases Agenda for Inaugural Cell & Gene Exchange

WASHINGTON, DC -- (Marketwired) -- 05/09/17 -- The Alliance for Regenerative Medicine (ARM) today released the agenda for the inaugural Cell & Gene Exchange, the only partnering conference that brings together the regulatory, business and patient advocacy communities across the cell and gene therapy sectors. Co-produced by ARM and EBD Group and held in partnership with Global Genes, the event will take place May 22 and 23 in Washington, D.C."Our industry is on the cusp of some truly re ...


09.05.2017

Accelerating Pace of Approvals and a Strong Development Pipeline Indicate Vigorous Growth for New Biotech Products, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 05/09/17 -- Biopharmaceuticals accounted for 35% of all new drug approvals in the United States from 2006 through 2016, and a robust development pipeline suggests that the recent increased pace of biotech approvals will continue for the next decade, according to a newly completed assessment from the .The annual pace of 13 new biotech products approvals by the U.S. Food and Drug Administration during the study period accelerated to more than 20 per year during 2014 ...


09.05.2017

Fatty Liver Disease Market Covering In-Depth Analysis of Diseases, Targets & Therapies, Growth Driven by Premium Innovation

Albany, New York, 04 May 2017: According to the current health sector trends, the fatty liver disease market is booming due to the rise in lifestyle related disorders. Market Research Hub (MRH) has included the new study to its vast repository of research studies which is titled as, ‘‘Frontier Pharma : Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products’’. The report reveals the newest research, innovations and business possibilit ...


05.05.2017

The Oncolytic Virus Market Driven by Latest Scientific Research & Acquisitions Showcases Business Potential till 2017

Albany, New York, May 04, 2017: Currently, the health industry is gaining remarkable benefits from the scientific research sector. This phenomenal shift is seen as one of the many contributing factors towards the rise of the oncolytic virus industry. New entrants can acquire a better advantage, through the latest report titled as “The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities”, which has been added to the huge database of Ma ...


04.05.2017

Global Market Analysis of MediPoint: Sports Medicine Forecasts Potential Growth Driven by Orthobiologics Development

Albany, New York, May 04, 2017: Rising incidences of sports related injuries worldwide is anticipated to be high impact rendering driver for the lucrative growth of sports medicine market. This growth in the sports medicine market is expected to continue in the coming years also, mainly driven by young athletes injuring themselves more and rise in obesity and growing elderly population that wishes to continue their recreational activity. This has been clearly stated in the latest study, added to ...


04.05.2017

Aevi Genomic Medicine to Host Conference Call to Announce First Quarter and Discuss Recent Business Updates

PHILADELPHIA, PA -- (Marketwired) -- 05/03/17 -- (NASDAQ: GNMX) (the Company) announced today it will host a conference call and live audio webcast on Wednesday, May 10, 2017 at 8:30 a.m. EDT to report financial results for the first quarter and discuss recent business updates.In order to participate in the conference call, please dial (888) 481-2845 (domestic) or (719) 325-2327 (international). The conference passcode is 9118660.The live webcast can be accessed under "Events" in the ...


03.05.2017

MedZone Adds Experienced Sports Industry Veteran to Advisory Board

LENEXA, KS -- (Marketwired) -- 05/01/17 -- , a leading manufacturer of topical skin solutions for active individuals, announces today its appointment of Thomas Rogge, to the company''s advisory board. Rogge, former CEO of Cramer Products, a leading sports medicine manufacturer and distributor, whose leadership is credited for assisting Cramer Products in a series of acquisitions and helping grow the company over his 23-year tenure, joins the MedZone team with unparalleled experience i ...


01.05.2017

Medfellowship.com to continue improving its services as it looks to win more customers

London, UK, April 29th 2017- medfellowship.com has continued to improve its services as it looks to win more customers. The company, which has been successful in the past four months, has been working hard to ensure that it epitomizes reliability in the delivery of its med fellowship services. According to a lately released statement by the company , many service providers offering med fellowship writing services fail to meet their customer''s vital demand which is delivering what the ...


29.04.2017

Cannabis Life Conference 2017

TORONTO, ONTARIO -- (Marketwired) -- 04/28/17 -- The , a two day event packed with education and action, is coming to the in Toronto May 13-14! This exciting event will provide an informative journey for those passionate about cannabis, or curious, as they explore the opportunities cannabis holds as an alternative medicine. Attendees will experience a guided, behind the scenes tour into the emerging medicinal industry through a variety of intriguing panel topics, impactful keynote speakers, and ...


28.04.2017

Aevi Genomic Medicine to Present at the 42nd Annual Deutsche Bank Health Care Conference

PHILADELPHIA, PA -- (Marketwired) -- 04/27/17 -- (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the 42nd Annual Deutsche Bank Health Care Conference on Thursday, May 4, 2017 at 1:10 p.m. EDT at the InterContinental Boston Hotel in Boston, MA.A live webcast of the presentation can be accessed under "Presentations" in the Investors section of the Company''s website at or you may use the link:Aevi Geno ...


27.04.2017

Yorktel Unveils Latest FeatherMed Portable Telehealth Kit at ATA 2017

ORLANDO, FL -- (Marketwired) -- 04/24/17 -- Today from booth 1133 at , the annual conference of the American Telemedicine Association (ATA), Yorktel () unveiled enhancements to its mobile telehealth kit, , which empowers caregivers with customization, flexibility, interoperability and versatility to improve clinical workflows and provide a higher level of patient-centric care.FeatherMed kits combine FDA-approved medical diagnostic tools and Yorktel''s secure communication software app ...


24.04.2017

Aevi Genomic Medicine Presents Updated Results from SAGA Trial of AEVI-001 at the 6th World Congress on ADHD

PHILADELPHIA, PA -- (Marketwired) -- 04/20/17 ---- Novel genetic mutations predictive of response to AEVI-001 found in approximately 10% of pediatric ADHD patients ---- New results clarify a path forward for the continued development of AEVI-001 in ADHD patients and potential future development in other neurodevelopmental disorders --(NASDAQ: GNMX) (the Company) today announced updated responder data from a subset of genomically identified patients in the SAGA trial of AEVI-001 in adolescent Att ...


20.04.2017

PolarityTE(TM), Inc. Enters Formal Agreement with Cell Therapy and Regenerative Medicine, A Leading Cell Therapy Manufacturer in the Intermountain West

SALT LAKE CITY, UT -- (Marketwired) -- 04/20/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces the signing of a manufacturing agreement with Cell Therapy and Regenerative Medicine ("CTRM") at the University of Utah School of Medicine. CTRM is the established manufacturer of hematopoietic stem cell transplants for renowned institutions of the Salt Lake region such as the Huntsman Cancer Institute and Primary Children''s Hospital. In addition, CTRM manufa ...


20.04.2017

Medicine Man Technologies Files its 2016 Annual Report and Issues Revenue Guidance for Q1 2017

DENVER, CO -- (Marketwired) -- 04/18/17 -- Medicine Man Technologies Inc. (OTCQB: MDCL), one of the country''s leading cannabis branding and consulting companies, announced that the Company has filed its 2016 Annual Report on Form 10-K for the year ended December 31, 2016, and is providing guidance related to its first quarter 2017 performance.According to market research firm ArcView, the U.S. cannabis industry made $6.7 billion in sales in 2016. Today, 28 states and the District of ...


18.04.2017

PolarityTE(TM), Inc. Recruits Key Additions to Management

SALT LAKE CITY, UT -- (Marketwired) -- 04/18/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces the recruitment of six new members to its growing team with specific expertise and experience in government and defense contracts, intellectual property and FDA legal strategy, and translational research and development.Chairman and Chief Executive Officer, Denver M. Lough, MD, PhD stated, "With such recent and significant growth, Polarity is proud to announce that we have r ...


18.04.2017

Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer at Asana Medical, Inc.

MIAMI LAKES, FL -- (Marketwired) -- 04/18/17 -- ., ("Asana," the "Company"), a regenerative medicine company that is developing a novel treatment for Inflammatory Bowel Disease ("IBD"), including Ulcerative Colitis and Crohn''s Disease, is pleased to announce that Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed as its Chief Business Officer.Mr. Andersen brings to Asana an impressive tr ...


18.04.2017

Stamford Dentist Earns Diplomate Status with the American Sleep and Breathing Academy

STAMFORD, CT -- (Marketwired) -- 04/18/17 -- Dr. Edward Shukovsky was recently named a Diplomate of the American Sleep and Breathing Academy (ASBA), meaning he has demonstrated strong proficiency in the area of dental sleep medicine (treating sleep disorders such as sleep apnea and snoring). This classification comes along with certification from the American Board of Sleep and Breathing. To earn this title, the Stamford dentist was required to complete at least 50 hours of continuing education ...


18.04.2017

New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus(R) CAD Blood Test to Help Safely Direct Cardiovascular Care

REDWOOD CITY, CA -- (Marketwired) -- 04/12/17 -- , a molecular diagnostics company specializing in , announced today the publication of results from the multi-center, community-based PRESET Registry in the peer-reviewed journal, The American Journal of Medicine.(1) The study results provided further confirmation of the clinical utility of the to help clinicians in real-world practice determine if their patients'' symptoms are due to a blockage in the heart arteries, and if referral t ...


12.04.2017

PolarityTE(TM) Inc. Announces Completion of Merger and Acquires Important Intellectual Property for Regenerative Medicine Programs

SALT LAKE CITY, UT -- (Marketwired) -- 04/07/17 -- PolarityTE™, Inc., (NASDAQ: COOL) today announced the completion of a previously announced merger. The Company will continue to trade under the NASDAQ symbol COOL.Denver Lough, Chairman and Chief Executive Officer of Polarity, stated, "We are thrilled and excited to announce the completion of this merger, which we believe dramatically propels the future development of PolarityTE™. Numerous parties have dedicated tremendous amounts of work ...


07.04.2017

The Alliance for Regenerative Medicine Releases Agenda for Fifth Annual Cell & Gene Therapy Investor Day

WASHINGTON, DC -- (Marketwired) -- 04/06/17 -- The Alliance for Regenerative Medicine (ARM) today released the complete agenda for its upcoming fifth annual Cell & Gene Therapy Investor Day, taking place April 27, 2017 in Boston, MA. This event, co-hosted by Piper Jaffray and held in partnership with Cowen and Company is the only investor conference specifically focused on cell and gene therapies, offering exclusive access to the field''s most promising companies.This year'&# ...


06.04.2017

Aevi Genomic Medicine to Present at the 16th Annual Needham Healthcare Conference

PHILADELPHIA, PA -- (Marketwired) -- 03/30/17 -- (NASDAQ: GNMX) (the Company) announced today that Brian D. Piper, Chief Financial Officer, will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017 at 10:00 a.m. EDT at the Westin New York Grand Central Hotel in New York City.A live webcast of the presentation can be accessed under "Presentations" in the Investors section of the Company''s website at or you may use the link:Aevi Genomics Medi ...


30.03.2017

Grass Valley Acupuncture Chinese Medicine Cleansing Body Report Launched

Dharma Acupuncture has launched a new report on the benefits of Chinese medicine and acupuncture for cleansing the body in time for spring. This time of year is described as one of the best for detoxing the body and ensuring optimum health heading into summer. As part of this process, people can alter their diet to a lighter, healthier menu. More information can be found at: http://dharmaacupuncture.com. The site explains that Lisa Swanson has been in the field of natural medicine for over 15 ...


28.03.2017

Global Burn Surgery Expert Dr. Stephen Milner is Recruited from Role as Director of The Johns Hopkins Burn Center and is Appointed as Chief Clinical Officer of PolarityTE(TM), Inc.

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/27/17 -- PolarityTE™, Inc. ("Polarity") (NASDAQ: COOL) announces that Dr. Stephen Milner (drstephenmilner.org) will join the company in a full-time capacity as Chief Clinical Officer following his resignation from Johns Hopkins as Professor of Plastic and Reconstructive Surgery and Pediatrics and Director of the Burn Center on March 30, 2017.As Chief Clinical Officer, Dr. Milner will utilize his extensive network of burn and wound care surge ...


27.03.2017

Aevi Genomic Medicine Provides Top-line Results from the SAGA Trial of AEVI-001

PHILADELPHIA, PA -- (Marketwired) -- 03/20/17 --Trial did not meet primary endpoint (overall ADHD-RS), however showed encouraging trend in improvement at highest dose (400 mg BID)Strong trend of efficacy in ADHD-RS inattention subscale (p=0.0515 vs placebo)Clear signal of efficacy and benefit to patientsADHD-RS response rate 70% (p=0.0067 vs placebo)CGI-I response rate 57% (p=0.0155 vs placebo)Well tolerated with no serious adverse eventsConference call scheduled for 8:30 AM ET(NASDAQ: GNMX) (th ...


20.03.2017

Aevi Genomic Medicine to Present at the Oppenheimer 27th Annual Healthcare Conference

PHILADELPHIA, PA -- (Marketwired) -- 03/15/17 -- (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the Oppenheimer 27th Annual Healthcare Conference on Wednesday, March 22, 2017 at 3:20 p.m. EDT at the Westin New York Grand Central in New York City.A live webcast of the presentation can be accessed under "Presentations" in the Investors section of the Company''s website at or you may use the link:Aevi ...


15.03.2017

Alliance for Regenerative Medicine Comments on Nomination of Scott Gottlieb as FDA Commissioner

WASHINGTON, DC -- (Marketwired) -- 03/13/17 -- The Alliance for Regenerative Medicine (ARM) today issued the following statements on the Trump Administration''s nomination of Scott Gottlieb, M.D., as commissioner of the U.S. Food and Drug Administration (FDA).ARM Chairman Robert Preti, Ph.D. said, "As a former practicing physician, FDA deputy commissioner and senior policy advisor for the Centers for Medicaid and Medicare Services, Dr. Gottlieb is a great choice to oversee the FD ...


13.03.2017

PolarityTE(TM) Inc. Stockholders Approve Merger

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/13/17 -- PolarityTE™, Inc., ("Polarity") (NASDAQ: COOL) today announced the voting results from it special meeting (the "Meeting") held on March 10, 2017.A total of 3,369,498 shares of common stock, including shares of common stock underlying shares of outstanding preferred stock were represented at the Meeting. The shareholders voted on and approved all matters brought before the Meeting and obtained over 99% votes in favor to con ...


13.03.2017

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

PHILADELPHIA, PA -- (Marketwired) -- 03/09/17 -- (NASDAQ: GNMX)(the Company) announced today recent progress and financial results for the three and twelve months ended December 31, 2016."2016 was an important and productive year for the Company," said Mike Cola, CEO of Aevi Genomic Medicine. "We made significant progress, advancing both our genomic medicine strategy and our lead program, AEVI-001 in the Phase 2/3 SAGA trial in adolescents with mGluR+ ADHD. We remain on track to ...


09.03.2017

Streamlined Development Process for Certain New Drug Applications Is Not Facilitating Shorter Approval Times, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 03/08/17 -- The 505(b)(2) approval pathway for new drug applications in the United States, aimed at avoiding unnecessary duplication of studies performed on a previously approved drug, has not led to shorter approval times, according to a recently completed analysis conducted by the ."While the 505(b)(2) regulatory pathway has been highly successful in bringing new therapies to market from 2009 through 2015, drug products approved under this pathway had a lon ...


08.03.2017

PolarityTE(TM) Inc. Appoints Business Strategy and Innovation Expert Jeff Dyer, MBA, PhD to Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 03/08/17 -- , (NASDAQ: COOL) today announced it has appointed Jeff Dyer, MBA, PhD, expert in business strategy and innovation to its Board of Directors."As we bring the vision of PolarityTE™ to fruition, we are excited to announce the appointment of a world class business strategist and scholar in innovation like Jeff Dyer to our Board of Directors. His career both working in the formative years of Bain & Company and studying the most innovative ...


08.03.2017

The Alliance for Regenerative Medicine Releases 2016 Annual Data Report, Highlighting Sector Trends and Metrics

WASHINGTON, DC -- (Marketwired) -- 03/07/17 -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2016 annual data report, offering an in-depth look at trends and metrics for the cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector.Using data provided by ARM''s data partner Informa and compiled and analyzed by ARM''s staff, the report details industry-specific statistics and trends from more than 730 lead ...


07.03.2017

Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/03/17 -- Qu Biologics Inc., a biopharmaceutical company developing (SSIs) that aim to "reboot" the body''s innate immune system, reports positive genetic analyses of their recently completed Phase 2 clinical studies in Crohn''s Disease (CD) and Ulcerative Colitis (UC). These findings suggest that, for the first time in the field of inflammatory bowel disease (IBD), personalized medicine and the application of gene ...


03.03.2017

Gaithersburg Energy Healing Alternative Medicine Benefits Report Released

EnergyMDT has released a report in to the benefits of energy healing as a non invasive alternative medicine. EnergyMDT offers a series of energy intuitive sessions at their offices in Gaithersburg or long distance via Skype. For more information please visit: http://energymdt.com/individual-sessions-body. EnergyMDT states that their mission is "to help beings grow and transform with the help of multi dimensional energies as we become a conscious society." They explain that using ener ...


03.03.2017

PolarityTE(TM) Inc. Appoints Artificial Intelligence and Cognitive Computing Leader Burke Powers as VP of Product Development

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/28/17 -- , (NASDAQ: COOL) today announced it has appointed Burke Powers as Vice President of Product Development. Mr. Powers has extensive experience building and commercializing products both in healthcare and other sectors utilizing artificial intelligence and big data anlytics."The addition of Burke Powers to PolarityTE marks yet another major milestone as we assemble the pieces to fulfill our vision to approach tissue engineering from a new p ...


28.02.2017

Aevi Genomic Medicine to Present at the Cowen and Company 37th Annual Health Care Conference

PHILADELPHIA, PA -- (Marketwired) -- 02/27/17 -- (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the Cowen and Company 37th Annual Health Care Conference in Boston, MA on Monday, March 6, 2016 at 4:40 p.m. EST at the Boston Marriott Copley Place.A live webcast of the presentation can be accessed under "Presentations" in the Investors section of the Company''s website at or you may use the link:Aevi G ...


27.02.2017

Italtel And Exprivia To Launch New Telemedicine System

Milan, February 24, 2017 – Italtel, a leading telecommunications company in IT System Integration, managed services, Network Functions Virtualization (NFV) and all-IP solutions, and Exprivia, an international group enabling the digital transformation process through added value solutions today announced they will launch an advanced telemedicine solution. The solution brings together Italtel’s DoctorLINK open web platform with Exprivia’s eLifeCare, revolutionizing home care by providing the req ...


24.02.2017

PolarityTE(TM) Inc. Regains Compliance With NASDAQ Independent Director Requirement

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/22/17 -- , (NASDAQ: COOL) today announced it has received formal notification from the Listing Qualifications Department of The NASDAQ Stock Market ("NASDAQ") notifying PolarityTE™ that it has regained compliance with Listing Rule 5605(b)(1), the independent director requirement for continued listing on The NASDAQ Stock Market, with the appointment of Mr. Steve Gorlin and Dr. Jon Mogford, and that the matter is now closed. PolarityTE™'& ...


22.02.2017

The Alliance for Regenerative Medicine Publishes Position on Hospital Exemption of Advanced Therapy Medicinal Products in Europe

BRUSSELS, BELGIUM and WASHINGTON, DC -- (Marketwired) -- 02/16/17 -- The (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine and advanced therapies sector, today announced it has published its position on Hospital Exemption (HE) in response to vastly different interpretations and implementations across the European Union of Article 3(7) of Directive 2001/83/EC within article 28 (2) of the Advanced Therapy Medicinal Products (A ...


16.02.2017

PolarityTE(TM) Inc. Appoints Jon Mogford, PhD to the Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/16/17 -- , (NASDAQ: COOL) today announced it has appointed Jon Mogford, PhD to the Board of Directors. Dr. Mogford has extensive experience in regenerative medicine and wound healing, with a long track record of leading large research institutions. He currently oversees research strategy as Vice Chancellor for Research across the entire Texas A&M University System, and led significant expansion and collaborations while serving as Deputy Director o ...


16.02.2017

Aevi Genomic Medicine Announces 2017 Investor Day

PHILADELPHIA, PA -- (Marketwired) -- 02/15/17 -- (NASDAQ: GNMX) (the Company) announced that it will host an Investor Day with senior management and key opinion leaders to discuss AEVI-001 and opportunities in the ADHD market. The event will be held at the NASDAQ Market Site in New York City on Wednesday, February 22, 2017 with breakfast beginning at 8:30 a.m. Eastern Time and speaker presentations beginning at 9:00 a.m. Eastern Time.The event will include presentations by key opinion leaders i ...


15.02.2017

The Alliance for Regenerative Medicine Releases Statement in Response to National Academies Report on Human Genome Editing

WASHINGTON, DC -- (Marketwired) -- 02/14/17 -- The National Academies of Sciences, Engineering and Medicine today issued a report that examines the scientific, clinical, ethical, legal and social implications of human genome editing. The Alliance for Regenerative Medicine (ARM) believes that genomic medicines, including genome editing, hold great promise for the treatment of a multitude of hereditary and acquired diseases where there is presently no effective treatment available.ARM issued the ...


14.02.2017

swyMed Introduces the DOT Telemedicine Backpack, Enabling Connectivity for Real-Time Mobile Video Consultations from Any Location

LEXINGTON, MA -- (Marketwired) -- 02/14/17 -- , a provider of exceptional-quality video telemedicine solutions, today unveiled the . It is the first lightweight, mobile telemedicine solution that enables field care providers to conduct high quality, reliable, real-time video consults with physicians to treat patients even in the most remote areas or on the go. Leveraging swyMed''s patent-pending video technology, the DOT Telemedicine Backpack delivers smooth, reliable connectivity for ...


14.02.2017

Patented Medicine Prices Review Board seeks applicants for Chairperson and Board member positions

OTTAWA, ONTARIO -- (Marketwired) -- 02/13/17 -- Patented Medicine Prices Review BoardThe Patented Medicine Prices Review Board (PMPRB) is seeking applicants for membership on the Board by way of open, transparent, and merit-based Governor in Council selection processes for the positions of Chairperson and Board member.Members of the Board are part-time, Governor in Council appointees who preside over hearings into allegations of excessive drug pricing brought by PMPRB staff against patent-holdi ...


13.02.2017

PolarityTE(TM) Inc. Appoints Regenerative Medicine Pioneer Steve Gorlin to the Board of Directors

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 02/09/17 -- (NASDAQ: COOL) today announced it has appointed Steve Gorlin to the Board of Directors. Mr. Gorlin has extensive experience building successful biotechnology companies, and is a leader in regenerative medicine, pharmaceutical drug and medical device research and development."We are extremely excited to announce Steve Gorlin as a new member of the PolarityTE™ Board of Directors. With over 40 successful years in the field, he remains a le ...


09.02.2017

Aevi Genomic Medicine to Present at the Leerink Partners 6th Annual Global Healthcare Conference

PHILADELPHIA, PA -- (Marketwired) -- 02/09/17 -- (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola, President and Chief Executive Officer, will present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 10:30 a.m. EST at the Lotte New York Palace, New York, NY.A live webcast of the presentation can be accessed under "Presentations" in the Investors section of the Company''s website at or you may use the link:Aev ...


09.02.2017

The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Fifth Annual Cell & Gene Therapy Investor Day

WASHINGTON, DC -- (Marketwired) -- 02/02/17 -- The Alliance for Regenerative Medicine (ARM) today announced its annual Cell & Gene Therapy Investor Day will take place April 27, 2017 in Boston, MA. The event is co-hosted by leading investment firm Piper Jaffray and held in partnership with Cowen & Co."Cell and gene therapies, including gene editing technologies and tissue engineering, are providing significant investment opportunities for institutional, venture, corporate strategic ...


02.02.2017

swyMed Announces Formation of Scientific Advisory Board

LEXINGTON, MA -- (Marketwired) -- 01/31/17 -- , a provider of exceptional-quality video telemedicine solutions, today announced the creation of its Scientific Advisory Board (SAB) with four key appointments: Lester Wold, M.D.; James McCarthy, M.D.; Ronald Merrell, M.D.; and Noah Rosen, M.D. The Scientific Advisory Board will advise swyMed on the highest value applications for swyMed''s truly mobile telemedicine solutions, and how innovative healthcare providers can further use the tec ...


31.01.2017

Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome

PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead investigational drug, AEVI-001 (NFC-1), in children with 22q11.2 Deletion Syndrome (22q DS), a rare disorder caused by an abnormality found on the 22nd chromosome. The trial will evaluate the changes in symptoms associated with three neuropsychiatric disorders -- including anxiety, attention deficit ...


31.01.2017

The Alliance for Regenerative Medicine to Host "21st Century Cures for Cell & Gene Therapies" Webinar on February 2, 2017

WASHINGTON, DC -- (Marketwired) -- 01/30/17 -- The (ARM) today announced it will host a free webinar titled "Understanding the 21st Century Cures Act for Cell & Gene Therapies." During this one-hour live event, Michael Werner, Executive Director for ARM will be joined by Director Wilson W. Bryan, M.D., and Deputy Director Rachael F. Anatol, Ph.D., of the U.S. Food and Drug Administration''s (FDA) Center for Biologics Evaluation and Research (CBER) Office of Tissues and ...


30.01.2017

Zywie CEO and Founder, Latha Ganeshan, Receives Innovation Award from Georgia Bio

ATLANTA, GA -- (Marketwired) -- 01/26/17 -- Latha Ganeshan, the CEO and founder of , has been named a 2017 Innovation Award Winner by Georgia Bio, the state''s life science industry association. The Georgia Innovation Award honors the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create unique technology.Zywie is a medtech company that uses technology to improve the early detection and precise remote monitoring ...


26.01.2017

The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

WASHINGTON, DC -- (Marketwired) -- 01/19/17 -- The (ARM) today announced the formal launch of the international for regenerative medicines (SCB), a public-private partnership for coordinating, prioritizing and supporting standards that advances process, measurement and analytical techniques to support the global availability of products across the gene and gene-modified cell therapy, cell therapy, cell-based drug discovery, tissue engineering and biomaterials sectors."Development of ind ...


19.01.2017

Patented Medicine Prices Review Board Will Hear Evidence in the Matter of the Price of Orphan Drug Soliris

OTTAWA, ONTARIO -- (Marketwired) -- 01/11/17 -- Patented Medicine Prices Review BoardThe Patented Medicine Prices Review Board (the Board) will hold a public hearing in the matter of the price of the patented medicine Soliris and Alexion Pharmaceuticals Inc. (Alexion), the pharmaceutical company that exercises patent rights for Soliris and sells the medicine in Canada. The hearing is scheduled to take place from 9:00 a.m. to 5:00 p.m. (EST) from January 16 to January 19 and from January 23 to J ...


11.01.2017

Poor Physician and Nurse Engagement Contributes to Low Patient Recruitment Rates, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 01/11/17 -- Although physicians and nurses are familiar with, and comfortable discussing, clinical trials, they refer a mere fraction of their patients for these studies, reflecting, in part, a failure by sponsors, contract research organizations, and investigative site personnel to engage health care providers as partners in the clinical research process, according to a recently completed analysis conducted by the .The study, based on a survey of 2,000 physicians ...


11.01.2017

Majesco Entertainment Company Reports Name Change to PolarityTE(TM), Inc.

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 01/10/17 -- (NASDAQ: COOL) following its previous announcement that it signed a definitive merger agreement with a Nevada corporation , (the "Merger") today announced that the Company''s name has been changed to PolarityTE™, Inc., effective with The NASDAQ Capital Market at the open of business on January 11, 2017. The Company''s new CUSIP will be 731094108 and its common stock will continue to trade under the symbol &quo ...


10.01.2017

PHZIO Telehealth Webinar Series Reminder

CULVER CITY, CA -- (Marketwired) -- 01/09/17 -- eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company is pleased to announce that it will begin offering free weekly webinar sessions that are part of our curriculum to educate PT clinicians on the value of treating patients utilizing our PHZIO platform. PT''s, clinical owers and or investors int ...


09.01.2017

"Unbreakable" New Year''s Resolution: Help Your Blood Pressure, Help Indigenous Peoples

Foresthill, CA, Jan 9, 2017 -- First Nation peoples, like Native Americans, are respected by natural medicine practitioners for their insights into effective non-drug approaches for disease. Dr. David DeRose, host of the syndicated health radio broadcast, "American Indian Living," has teamed up with another physician, Dr. Greg Steinke, and a nurse practitioner, Trudie Li, to author "Thirty Days to Natural Blood Pressure Control." This new book describes many of the best natur ...


09.01.2017



All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 169


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.